34
Participants
Start Date
December 31, 2025
Primary Completion Date
August 31, 2026
Study Completion Date
December 31, 2026
Prucalopride 1 MG
The study drug Tab. Prucalopride 1 mg (30 tablets) will be dispensed to the participant. The drug will be procured at the local site manufactured in India only.They will be explained to take one tablet of 1 mg Prucalopride per oral in the morning. The participants will continue their antipsychotic regimen as per orders of their consultant and will continue to purchase their psychiatric medications as earlier. At the end of week 1, participants will be assessed for side effects via telephonic conversation.
K S Hegde Medical Academy,, Mangalore
Fogarty International Center of the National Institute of Health
NIH
K S Hegde Medical Academy
UNKNOWN
University of Pittsburgh
OTHER